nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Mercaptopurine—Crohn's disease	0.443	0.562	CbGbCtD
Adefovir Dipivoxil—ABCC4—Mercaptopurine—Crohn's disease	0.213	0.27	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Mercaptopurine—Crohn's disease	0.133	0.169	CbGbCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—VAMP3—Crohn's disease	0.0101	0.141	CbGpPWpGaD
Adefovir Dipivoxil—NME1—mouth—Crohn's disease	0.00676	0.122	CbGeAlD
Adefovir Dipivoxil—SLC22A3—Organic cation transport—SLC22A5—Crohn's disease	0.00608	0.0852	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Organic cation transport—SLC22A4—Crohn's disease	0.00608	0.0852	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Carbidopa—Mesalazine—Crohn's disease	0.00487	1	CbGdCrCtD
Adefovir Dipivoxil—AK2—mammalian vulva—Crohn's disease	0.00444	0.0801	CbGeAlD
Adefovir Dipivoxil—Nephrotoxicity—Mesalazine—Crohn's disease	0.00437	0.0545	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00412	0.0578	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00412	0.0578	CbGpPWpGaD
Adefovir Dipivoxil—NME1—skin of body—Crohn's disease	0.00374	0.0674	CbGeAlD
Adefovir Dipivoxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00371	0.0521	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00371	0.0521	CbGpPWpGaD
Adefovir Dipivoxil—NME2—epithelium—Crohn's disease	0.0037	0.0667	CbGeAlD
Adefovir Dipivoxil—AK4—mammalian vulva—Crohn's disease	0.00329	0.0592	CbGeAlD
Adefovir Dipivoxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0031	0.0435	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0031	0.0435	CbGpPWpGaD
Adefovir Dipivoxil—NME1—lymphoid tissue—Crohn's disease	0.00303	0.0546	CbGeAlD
Adefovir Dipivoxil—NME1—digestive system—Crohn's disease	0.00299	0.0539	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—Crohn's disease	0.00294	0.0529	CbGeAlD
Adefovir Dipivoxil—AK4—digestive system—Crohn's disease	0.00288	0.052	CbGeAlD
Adefovir Dipivoxil—NME2—lymphoid tissue—Crohn's disease	0.00285	0.0514	CbGeAlD
Adefovir Dipivoxil—NME2—digestive system—Crohn's disease	0.00282	0.0508	CbGeAlD
Adefovir Dipivoxil—SLC22A3—mouth—Crohn's disease	0.00264	0.0476	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00256	0.0319	CcSEcCtD
Adefovir Dipivoxil—Foetor hepaticus—Mesalazine—Crohn's disease	0.00245	0.0305	CcSEcCtD
Adefovir Dipivoxil—Nephropathy toxic—Mesalazine—Crohn's disease	0.00242	0.0302	CcSEcCtD
Adefovir Dipivoxil—AK2—lymph node—Crohn's disease	0.00223	0.0401	CbGeAlD
Adefovir Dipivoxil—Liver disorder—Mesalazine—Crohn's disease	0.00204	0.0254	CcSEcCtD
Adefovir Dipivoxil—NME1—lymph node—Crohn's disease	0.00171	0.0308	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—Crohn's disease	0.00165	0.0297	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—Crohn's disease	0.00161	0.029	CbGeAlD
Adefovir Dipivoxil—Pancreatitis—Mercaptopurine—Crohn's disease	0.00157	0.0196	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—ITGA4—Crohn's disease	0.00154	0.0217	CbGpPWpGaD
Adefovir Dipivoxil—Hepatocellular injury—Azathioprine—Crohn's disease	0.00153	0.019	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Mesalazine—Crohn's disease	0.00152	0.0189	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—smooth muscle tissue—Crohn's disease	0.00148	0.0267	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Mesalazine—Crohn's disease	0.00139	0.0173	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00135	0.0169	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—mammalian vulva—Crohn's disease	0.00133	0.024	CbGeAlD
Adefovir Dipivoxil—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00127	0.0158	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Prednisone—Crohn's disease	0.00126	0.0158	CcSEcCtD
Adefovir Dipivoxil—Fracture—Prednisone—Crohn's disease	0.00126	0.0158	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Azathioprine—Crohn's disease	0.00123	0.0154	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00121	0.017	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—digestive system—Crohn's disease	0.00113	0.0204	CbGeAlD
Adefovir Dipivoxil—Hepatic failure—Mesalazine—Crohn's disease	0.00112	0.014	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Mercaptopurine—Crohn's disease	0.00112	0.0139	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Mesalazine—Crohn's disease	0.00106	0.0132	CcSEcCtD
Adefovir Dipivoxil—Myopathy—Prednisone—Crohn's disease	0.00105	0.0131	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Mercaptopurine—Crohn's disease	0.00103	0.0129	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—SMAD3—Crohn's disease	0.000993	0.0139	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000946	0.0118	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Mesalazine—Crohn's disease	0.000945	0.0118	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Azathioprine—Crohn's disease	0.000938	0.0117	CcSEcCtD
Adefovir Dipivoxil—ABCC5—lymph node—Crohn's disease	0.000935	0.0168	CbGeAlD
Adefovir Dipivoxil—Liver function test abnormal—Mesalazine—Crohn's disease	0.000931	0.0116	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Prednisone—Crohn's disease	0.000907	0.0113	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000894	0.0111	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00089	0.0111	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mercaptopurine—Crohn's disease	0.000887	0.0111	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Mercaptopurine—Crohn's disease	0.000871	0.0109	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Mesalazine—Crohn's disease	0.000855	0.0107	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000832	0.0104	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000826	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000826	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000807	0.0101	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mercaptopurine—Crohn's disease	0.000794	0.0099	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Mesalazine—Crohn's disease	0.000789	0.00983	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000789	0.00983	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Mesalazine—Crohn's disease	0.000764	0.00952	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Mesalazine—Crohn's disease	0.000758	0.00944	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—SMAD3—Crohn's disease	0.000752	0.0105	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000744	0.0104	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000744	0.0104	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Mesalazine—Crohn's disease	0.000741	0.00924	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000735	0.00916	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Mesalazine—Crohn's disease	0.000729	0.00909	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mercaptopurine—Crohn's disease	0.000722	0.009	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Mesalazine—Crohn's disease	0.000698	0.0087	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Mesalazine—Crohn's disease	0.000693	0.00863	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Mesalazine—Crohn's disease	0.000689	0.00859	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Mesalazine—Crohn's disease	0.000686	0.00855	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Mesalazine—Crohn's disease	0.000684	0.00852	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—Crohn's disease	0.000668	0.012	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—Crohn's disease	0.000648	0.0117	CbGeAlD
Adefovir Dipivoxil—Diarrhoea—Mercaptopurine—Crohn's disease	0.000625	0.00779	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000621	0.00871	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000621	0.00871	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Azathioprine—Crohn's disease	0.000616	0.00768	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—F5—Crohn's disease	0.000615	0.00862	CbGpPWpGaD
Adefovir Dipivoxil—Flatulence—Mesalazine—Crohn's disease	0.000599	0.00746	CcSEcCtD
Adefovir Dipivoxil—Back pain—Mesalazine—Crohn's disease	0.000588	0.00732	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000586	0.00821	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Mercaptopurine—Crohn's disease	0.000581	0.00724	CcSEcCtD
Adefovir Dipivoxil—Rash—Mercaptopurine—Crohn's disease	0.000576	0.00718	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mercaptopurine—Crohn's disease	0.000575	0.00717	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Azathioprine—Crohn's disease	0.000568	0.00708	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000564	0.00703	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Mesalazine—Crohn's disease	0.000561	0.007	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mercaptopurine—Crohn's disease	0.000543	0.00676	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Azathioprine—Crohn's disease	0.000533	0.00664	CcSEcCtD
Adefovir Dipivoxil—Cough—Mesalazine—Crohn's disease	0.00053	0.00661	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Azathioprine—Crohn's disease	0.000529	0.00659	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Mesalazine—Crohn's disease	0.000517	0.00645	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Mesalazine—Crohn's disease	0.000517	0.00645	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000514	0.00721	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000514	0.0064	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000496	0.00618	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000491	0.00688	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Mesalazine—Crohn's disease	0.000486	0.00606	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Mesalazine—Crohn's disease	0.000485	0.00605	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Mesalazine—Crohn's disease	0.000482	0.006	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Mesalazine—Crohn's disease	0.000473	0.00589	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000471	0.00587	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00047	0.00586	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000463	0.0065	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PLA2G4F—Crohn's disease	0.000461	0.00647	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Prednisone—Crohn's disease	0.000452	0.00564	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000452	0.00563	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000445	0.00555	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Mesalazine—Crohn's disease	0.000436	0.00544	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Mesalazine—Crohn's disease	0.000431	0.00537	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Azathioprine—Crohn's disease	0.00043	0.00536	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Azathioprine—Crohn's disease	0.00043	0.00536	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000428	0.00533	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Prednisone—Crohn's disease	0.000417	0.0052	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000405	0.00505	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—MTMR3—Crohn's disease	0.000392	0.0055	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Mesalazine—Crohn's disease	0.000392	0.00488	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Mesalazine—Crohn's disease	0.000392	0.00488	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000387	0.00542	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000375	0.00526	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000375	0.00526	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Azathioprine—Crohn's disease	0.000372	0.00464	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Prednisone—Crohn's disease	0.000363	0.00452	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Mesalazine—Crohn's disease	0.000356	0.00443	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Mesalazine—Crohn's disease	0.000351	0.00437	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Azathioprine—Crohn's disease	0.000346	0.00431	CcSEcCtD
Adefovir Dipivoxil—Rash—Azathioprine—Crohn's disease	0.000343	0.00428	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Azathioprine—Crohn's disease	0.000343	0.00427	CcSEcCtD
Adefovir Dipivoxil—Headache—Azathioprine—Crohn's disease	0.000341	0.00425	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Mesalazine—Crohn's disease	0.000339	0.00423	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000338	0.00474	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000338	0.00474	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—GCKR—Crohn's disease	0.000331	0.00463	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Azathioprine—Crohn's disease	0.000323	0.00403	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Prednisone—Crohn's disease	0.000321	0.00401	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—PLA2G4F—Crohn's disease	0.00032	0.00448	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Mesalazine—Crohn's disease	0.000315	0.00393	CcSEcCtD
Adefovir Dipivoxil—Rash—Mesalazine—Crohn's disease	0.000313	0.0039	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Mesalazine—Crohn's disease	0.000312	0.00389	CcSEcCtD
Adefovir Dipivoxil—Headache—Mesalazine—Crohn's disease	0.000311	0.00387	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—FADS1—Crohn's disease	0.000306	0.00429	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Prednisone—Crohn's disease	0.000297	0.0037	CcSEcCtD
Adefovir Dipivoxil—Nausea—Mesalazine—Crohn's disease	0.000294	0.00367	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GPX4—Crohn's disease	0.000286	0.00401	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000282	0.00396	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000282	0.00396	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—GCKR—Crohn's disease	0.000276	0.00388	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Prednisone—Crohn's disease	0.000274	0.00341	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000273	0.00382	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MTMR3—Crohn's disease	0.000272	0.00381	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000272	0.00339	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000264	0.0037	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Prednisone—Crohn's disease	0.000257	0.00321	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Prednisone—Crohn's disease	0.000255	0.00318	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Prednisone—Crohn's disease	0.00025	0.00312	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—PLA2G4F—Crohn's disease	0.000242	0.0034	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000239	0.00298	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000238	0.00334	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000238	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000238	0.00333	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000234	0.00328	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Prednisone—Crohn's disease	0.000231	0.00288	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Prednisone—Crohn's disease	0.000228	0.00284	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000217	0.00305	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Prednisone—Crohn's disease	0.000214	0.00267	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—FADS1—Crohn's disease	0.000212	0.00297	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000211	0.00295	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Prednisone—Crohn's disease	0.000207	0.00258	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Prednisone—Crohn's disease	0.000207	0.00258	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—MTMR3—Crohn's disease	0.000206	0.00289	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000199	0.00279	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GPX4—Crohn's disease	0.000198	0.00278	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GCKR—Crohn's disease	0.000192	0.00269	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000191	0.00267	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000191	0.00267	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Prednisone—Crohn's disease	0.000188	0.00235	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—ALB—Crohn's disease	0.000187	0.00262	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Prednisone—Crohn's disease	0.000186	0.00231	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Prednisone—Crohn's disease	0.000179	0.00224	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	0.000178	0.00249	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000176	0.00246	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000172	0.00241	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000172	0.00241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000167	0.00235	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Prednisone—Crohn's disease	0.000167	0.00208	CcSEcCtD
Adefovir Dipivoxil—Rash—Prednisone—Crohn's disease	0.000165	0.00206	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Prednisone—Crohn's disease	0.000165	0.00206	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000165	0.00231	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000165	0.00231	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Prednisone—Crohn's disease	0.000164	0.00205	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.000163	0.00229	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—FADS1—Crohn's disease	0.000161	0.00225	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.000158	0.00222	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Prednisone—Crohn's disease	0.000156	0.00194	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—GPX4—Crohn's disease	0.00015	0.00211	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000148	0.00207	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000147	0.00206	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GCKR—Crohn's disease	0.000145	0.00204	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000143	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000143	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—F5—Crohn's disease	0.000141	0.00197	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RSPO3—Crohn's disease	0.000137	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000134	0.00188	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PLA2G4F—Crohn's disease	0.000131	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SEL1L—Crohn's disease	0.00013	0.00182	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000121	0.0017	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000119	0.00166	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—LTF—Crohn's disease	0.000116	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000116	0.00163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.000115	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTMR3—Crohn's disease	0.000111	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000107	0.0015	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PLA2G4F—Crohn's disease	0.000105	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000103	0.00144	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000101	0.00142	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—GCKR—Crohn's disease	9.36e-05	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.93e-05	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTMR3—Crohn's disease	8.93e-05	0.00125	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—ALB—Crohn's disease	8.8e-05	0.00123	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—FADS1—Crohn's disease	8.67e-05	0.00122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ITGA4—Crohn's disease	8.64e-05	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL3—Crohn's disease	8.43e-05	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	8.41e-05	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—ALB—Crohn's disease	8.28e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SLC11A1—Crohn's disease	8.28e-05	0.00116	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—RASGRP1—Crohn's disease	8.15e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GPX4—Crohn's disease	8.12e-05	0.00114	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GCKR—Crohn's disease	7.84e-05	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—Crohn's disease	7.7e-05	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	7.7e-05	0.00108	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.58e-05	0.00106	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HSPA1B—Crohn's disease	7.1e-05	0.000995	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RBX1—Crohn's disease	7.1e-05	0.000995	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—FADS1—Crohn's disease	6.96e-05	0.000975	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GPX4—Crohn's disease	6.51e-05	0.000913	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	6.33e-05	0.000887	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GCKR—Crohn's disease	6.29e-05	0.000882	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—UBE2D1—Crohn's disease	6.22e-05	0.000872	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ALB—Crohn's disease	6.1e-05	0.000855	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL2RA—Crohn's disease	5.9e-05	0.000827	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—Crohn's disease	5.34e-05	0.000748	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ALB—Crohn's disease	5.33e-05	0.000747	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—ALB—Crohn's disease	4.62e-05	0.000648	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMAD3—Crohn's disease	4.45e-05	0.000624	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.27e-05	0.000599	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—ALB—Crohn's disease	4.27e-05	0.000598	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—Crohn's disease	4.04e-05	0.000567	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—JAK2—Crohn's disease	3.97e-05	0.000556	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	3.85e-05	0.00054	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	3.69e-05	0.000518	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	3.22e-05	0.000451	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TYK2—Crohn's disease	2.9e-05	0.000407	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—JAK2—Crohn's disease	2.77e-05	0.000388	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CD4—Crohn's disease	2.63e-05	0.000368	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—Crohn's disease	2.61e-05	0.000366	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ALB—Crohn's disease	2.5e-05	0.00035	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—Crohn's disease	2.18e-05	0.000306	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—STAT3—Crohn's disease	2.03e-05	0.000285	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ALB—Crohn's disease	2e-05	0.000281	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—Crohn's disease	1.75e-05	0.000246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—IL6—Crohn's disease	1.42e-05	0.000199	CbGpPWpGaD
